本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Trevi Therapeutics Inc.

6.82
-0.0400-0.58%
成交量:112.94萬
成交額:776.40萬
市值:8.13億
市盈率:-15.34
高:6.98
開:6.85
低:6.71
收:6.86
資料載入中...
2022/05/09

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/07

重要事件披露

8-K - Current report
2022/03/17

重要事件披露

8-K - Current report
2022/03/17

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

重要事件披露

8-K - Current report
2022/03/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/24

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

重要事件披露

8-K - Current report
2022/01/26

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

重要事件披露

8-K - Current report
2022/01/05

重要事件披露

8-K - Current report